Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wen Qing Yin is a classic Chinese herbal formula first recorded in the Ming dynasty text “Bring Spring Back to Myriad Diseases” (Wan Bing Hui Chun, 1587). It is traditionally used to treat conditions characterized by blood heat and blood stagnation. The formula combines herbs that nourish and activate the blood (such as Angelica sinensis/Dang Gui), clear heat and toxins (such as Coptis/Huang Lian and Gardenia/Zhi Zi), promote blood circulation, stop bleeding, warm the menses, and cool the blood. Modern clinical applications include chronic uterine bleeding due to heat, irregular menstruation or excessive menstrual flow from blood heat or stagnancy in a deficiency conformation; it is also used for skin inflammation such as eczema or dermatitis with dry inflamed skin. Additional uses include support for menopausal symptoms like hot flashes and insomnia by balancing qi-blood dynamics[1][2][3][5]. The mechanism of action involves anti-inflammatory effects through clearing internal heat/toxins while supporting hematopoiesis/circulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wen Qing Yin.